Page 4 - Pharmaceuticals

Glenmark licenses oncology products from US-based APC Therapeutics

Glenmark to have for exclusive rights to a small molecule, oncology compound based on APC biology

Aurobindo Pharma receives US FDA approval for sevelamer oral suspension

Product is indicated to control serum phosphorus in patients with chronic kidney disease on dialysis

DCGI grants approval for AstraZeneca's inhaler to treat asthma

Symbicort Turbuhaler contains two active ingredients in one inhaler - budesonide and formoterol

Lupin launches antidepressant drug bupropion

The newly launched product is the generic version of Valeant Pharmaceuticals' Wellbutrin XL tablet

US FDA grants approval for ezetimibe tablet to Sun Pharma & Zydus Cadila

Ezetimibe tablet, which had annual US sales of $ 2.7 bn, is used to reduce high cholesterol levels

Strides Shasun receives US FDA approval for amantadine tablet

This tablet is used for treatment of Parkinson's disease & Shingles (herpes zoster) to reduce pain

Zydus Cadila receives US FDA nod for antifungal drug nystatin

The product, nystatin topical powder, will be manufactured at US facility of Zydus' arm Nesher

Hester Biosciences to set up animal vaccines facility in Tanzania

Manufacturing facility will cater to entire Africa, which imports more than 80% of its vaccines

Merck to collaborate with F-star to strengthen immuno-oncology portfolio

Merck to pay up to € 115 mn in upfront, R&D funding and milestone payments in the first 2 years

Chiltern acquires Japanese CRO Integrated Development Associates

Deal will allow Chiltern to integrate Japan and Asia into its global drug development network

Gufic Biosciences receives patents for two formulations in India

The company is also in the process of applying patents for the two formulations in other countries

Dr Reddy's launches bivalirudin injection in US

Bivalirudin, a direct thrombin inhibitor, is used to prevent blood clots in people

AstraZeneca sells antacid brand Neksium to Pfizer India for Rs 75 cr

Deal to help Pfizer, which also owns Gelusil brand, strengthen its presence in gastrointestinal area

Lyka Labs inks out-licensing deal with US-based generics firm

The market size of the licensed formulations is about $ 1.4 bn as per IMS March 2017, says Lyka

Glenmark receives US FDA approval for hypertension drug nebivolol

It is also eligible for 180 days exclusivity for the drug, a generic version of Forest's Bystolic

US FDA accepts application of Sun Pharma's partner Merck for tildrakizumab

Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis

Avery Dennison buys Finesse Medical to strengthen healthcare materials biz

Finesse Medical makes healthcare products used in the management of wound care and skin conditions

Dr Reddy's Labs receives US FDA nod for doxorubicin injection

DRL had partnered with Natco Pharma Ltd for developing the product, a generic version of Doxil

Biogen buys Remedy Pharmaceuticals' stroke drug Cirara

Biogen will pay $120 mn upfront payment plus potential milestone and royalty payments

Thermo Fisher Scientific buys Patheon for $7.2 billion

Patheon will facilitate Thermo Fisher's entry into the high-growth $40-billion CDMO market